Clinical Trial Update: 4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of everolimus in postmenopausal women with estrogen receptor–positive locally advanced or metastatic breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Breast Cancer | Phase 3 | Status: COMPLETED